In situ RHAMM protein expression in acute myeloid leukemia blasts suggests poor overall survival
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In situ RHAMM protein expression in acute myeloid leukemia blasts suggests poor overall survival
Authors
Keywords
-
Journal
ANNALS OF HEMATOLOGY
Volume 90, Issue 8, Pages 901-909
Publisher
Springer Nature
Online
2011-01-27
DOI
10.1007/s00277-011-1159-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RHAMM (CD168) Is Overexpressed at the Protein Level and May Constitute an Immunogenic Antigen in Advanced Prostate Cancer Disease
- (2015) Kilian M. Gust et al. NEOPLASIA
- Filling the mosaic of p53 actions: p53 represses RHAMM expression
- (2011) Samuel Godar et al. CELL CYCLE
- Expression of pSTAT5 predicts FLT3 internal tandem duplications in acute myeloid leukemia
- (2010) Ellen Christina Obermann et al. ANNALS OF HEMATOLOGY
- RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53
- (2010) Sindy Sohr et al. CELL CYCLE
- Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores
- (2010) Alexandar Tzankov et al. LEUKEMIA & LYMPHOMA
- Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia
- (2009) C. M. Santamaria et al. BLOOD
- Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study
- (2009) Anders Wahlin et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Coexpression of CD44 variant isoforms and receptor for hyaluronic acid−mediated motility (RHAMM, CD168) is an International Prognostic Index and C-MYC gene status−independent predictor of poor outcome in diffuse large B-cell lymphomas
- (2009) Sabine Nagel et al. EXPERIMENTAL HEMATOLOGY
- The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses
- (2009) Schmitt INTERNATIONAL JOURNAL OF ONCOLOGY
- Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas
- (2009) Shigeishi INTERNATIONAL JOURNAL OF ONCOLOGY
- Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis
- (2009) K. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells
- (2008) J. Greiner et al. CLINICAL CANCER RESEARCH
- Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer
- (2008) I Zlobec et al. GUT
- Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?
- (2008) C. A. Maxwell et al. JOURNAL OF CELL SCIENCE
- The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia
- (2008) K Giannopoulos et al. LEUKEMIA
- Diagnosis and Prognosis in Acute Myeloid Leukemia — The Art of Distinction
- (2008) Bob Löwenberg NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation